Average Insider

Where insiders trade, we follow

52W Low$28.66
Current$112.8086.1% above low, 13.9% below high
52W High$126.38

Filing Information

Accession Number0001193125-26-382456
Form Type4
Filing DateSep 4, 2026
DocumentView SEC Filing
Transactions
12
Total Shares
175,377
Total Value
$7,749,719.70
P&L
+99.0% (+$15,486.36)

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
President, Oncology
Common Stock
โ€”Sep 1, 2026Grant/Award138$113.38$15,646.444,206Directโ€”View Details
President, Oncology
Common Stock
โ€”Sep 1, 2026Grant/Award138$0.00$0.004,344Directโ€”View Details
President, Oncology
Common Stock
โ€”Sep 2, 2026Tax Withholding102$113.38$11,564.764,242Directโ€”View Details
President, Oncology
Common Stock
โ€”Sep 2, 2026Exercise/Conversion58,333$21.63$1,261,742.7962,575Directโ€”View Details
President, Oncology
Common Stock
โ€”Sep 2, 2026Sale23,600$109.35$2,580,674.1638,975Directโ€”View Details
President, Oncology
Common Stock
โ€”Sep 2, 2026Sale23,770$110.70$2,631,348.5115,205Directโ€”View Details
President, Oncology
Common Stock
โ€”Sep 2, 2026Sale1,537$111.37$171,180.7613,668Directโ€”View Details
President, Oncology
Common Stock
โ€”Sep 2, 2026Sale974$112.40$109,474.2912,694Directโ€”View Details
President, Oncology
Common Stock
โ€”Sep 2, 2026Sale1,606$113.72$182,632.2311,088Directโ€”View Details
President, Oncology
Common Stock
โ€”Sep 2, 2026Sale5,621$114.58$644,042.385,467Directโ€”View Details
President, Oncology
Common Stock
โ€”Sep 2, 2026Sale1,225$115.44$141,413.394,242Directโ€”View Details
President, Oncology
Stock option (right to buy)
(Common Stock)
DerivativeSep 2, 2026Exercise/Conversion58,333$0.00$0.00141,667Directโ€”View Details
Version: v26.7.3